Abstract
Pentylenetetrazol given in repeated convulsant doses to dogs completely paralyzed with a neuromuscular blocking agent produced a consistent hyperthermia at ambient temperatures above a critical range of 23 to 25°C, and a consistent hypothermia at lower temperatures. Increased cutaneous blood flow, with resulting loss of body heat, appears to be the major factor in the hypothermic response to pentylenetetrazol, whereas increased heat production, independent of skeletal muscle activity, appears to be the major factor in the hyperthermic response to the drug. Experiments on dogs with the spinal cord acutely sectioned at C4 to C6 indicate that the thermal responses to pentylenetetrazol are of central origin, but are not simply the result of an induced poikilothermia.
Footnotes
- Received December 11, 1958.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|